Sudeep Nagaraj | Immunotherapy | Best Researcher Award

Published on 17/06/202517/06/2025 by Top Pharmaceutical

Sudeep Nagaraj | Immunotherapy | Best Researcher Award

Dr. Sudeep Nagaraj, ICAR-NIVEDI, India

Dr. Sudeep Nagaraj is an accomplished molecular biologist and research scientist with a Ph.D. from GITAM University (2025) 🎓. He possesses extensive hands-on expertise in molecular genetics, cytogenetics, proteomics, virology, and phytochemistry 🧪🌿. With over six years of academic and research experience, he has served in various prestigious institutions including ICAR-NIVEDI and ICAR-IVRI 🏛️. Dr. Nagaraj has authored 20+ peer-reviewed publications on cytotoxicity, DNA barcoding, and viral epidemiology 📚. His primary research focus lies in virology and molecular diagnostics, especially lumpy skin disease in livestock 🐄🦠. He is known for blending academic rigor with applied research for public health impact 💡.

Publication Profile

Google Scholar

Education

Dr. Sudeep Nagaraj holds a Ph.D. in Molecular Biology from GITAM University (2025) 🧬, an MSc from SDUAHER, Tamaka Kolar (2016) 🧪, and a BSc from FGC, KGF (2012) 📚. His academic journey began at Chinmaya Vidyalaya, Kolar (SSLC, 2007) and continued through BGS PU College (PUC, 2009) 🏫. Professionally, he has accumulated diverse experience across esteemed research institutions and labs, contributing significantly to molecular and virology research 🧫. Additionally, he has one year of teaching experience in Molecular Biology at SIMS and RC, where he taught undergraduate students with dedication and clarity 🎓🧑‍🏫.

Experience

oDr. Sudeep Nagaraj has amassed rich experience through roles such as SRF at ICAR-NIVEDI (2021–present) 🧬, Young Professional-II at ICAR-IVRI (2020–2021) 🧫, and Research Scientist at Cytogene Diagnostics (2019–2020) 🔬. His journey also includes positions at SIMS and RC, QTLomics, and IDBR. He taught Molecular Biology at SIMS and RC for a year at the UG level 🎓. His hands-on skills span molecular genetics (PCR, DNA isolation, HRM), proteomics (SDS-PAGE, Bradford assay), cytogenetics (karyotyping), gene cloning, cell culture, virology (ELISA, virus titration), and phytochemistry (plant extract prep) 🧬🌿🧫.

Awards

Dr. Sudeep Nagaraj has been honored with several prestigious awards for his outstanding contributions to scientific research and innovation 🧠🔬. He received the Young Scientist Award at the International Conference on Science, Health, and Engineering held in Chennai on January 11, 2020 🏆. In 2021, he was conferred the Best Researcher Award at the International Research Awards on New Science Inventions on August 11 in Chennai 🥇. Most recently, in 2025, he was recognized once again with a Young Scientist Award from Scientific Laurels, celebrating his continued excellence in research 🚀📚.

Research Focus

Dr. Sudeep Nagaraj’s research centers around molecular virology, cytogenetics, and immunology, with a significant emphasis on Lumpy Skin Disease (LSD) in livestock 🐄. His work extends to plant-based cytotoxicity, DNA barcoding, and cell culture techniques, reflecting a strong interdisciplinary foundation 🌿🧪. His studies explore pathogen-host interactions, viral evolution, and molecular diagnostics, contributing vital insights into disease spillovers and viral epidemiology across species 🧠🔍. He also focuses on PBMC assays, ELISA, and nanoparticle toxicity, bridging biomedicine, virology, and phytochemistry. His impactful contributions aid in zoonotic disease management and therapeutic development 📊💉🌾.

Publication Top Notes

Lumpy Skin Disease (LSD) in Yak (Bos grunniens): An Evidence of Species Spillover from Cattle in India

Evaluation of In Vitro Cytotoxic Effects of Three Medicinal Plants on Peripheral Blood Mononuclear Cells (PBMC)

First evidence of lumpy skin disease in mithun (Bos frontalis) in India

An in vitro cytotoxic and genotoxic properties of Allamanda cathartica L. Latex green NPs on human peripheral blood mononuclear cells

Unravelling the genomic origins of lumpy skin disease virus in recent outbreaks

Evaluation of HCP5 and Chemokine C receptor type 5 gene polymorphisms in Indian psoriatic patients

DNA based identification of species of Zingiberaceae family plants using Bar-Hrm analysis

A SIMPLE, COSTEFFECTIVE, FAST AND EASY TO ISOLATE DNA PROTOCOL FROM HUMAN SAMPLES

Investigation of Comorbidity and Risk Analysis During Lumpy Skin Disease Outbreaks in India

Evaluation of invitro cytotoxic activity of parts of Murraya koenigii (curry) plant on human peripheral blood mononuclear cells

Separation and Optimisation of a Sucrose Density Gradient Centrifugation Protocol for Isolation of Peripheral Blood Mononuclear Cells (PBMC)

Fast and Easy Protocol of DNA Extraction from Fresh and Hard/Dried Plant Samples of Indian Spices

Nan Jiang | Nanomedicine | Best Researcher Award

Published on 16/06/202516/06/2025 by Top Pharmaceutical

Nan Jiang | Nanomedicine | Best Researcher Award

Dr. Nan Jiang, Peking University School and Hospital of Stomatology, China

Dr. Nan Jiang is a distinguished biomedical researcher with a Ph.D. from Peking University (2015) and training from Columbia University and NYU School of Medicine. 🧠🦷 Her pioneering research focuses on craniofacial development, aging, and regeneration, especially through nanomedicine and exosome technologies. 🚀🧪 She has published over 35 peer-reviewed articles and authored a book on stem cells in craniofacial regeneration 📘. With an H-index of 16 📊 and a U.S. patent on exosome-based diagnostics, Dr. Jiang is shaping the future of regenerative dentistry and tissue engineering. 🌟🧫 Her innovative work continues to impact both science and clinical practice.

Publication Profile

Scopus

Education

Dr. Nan Jiang earned her Ph.D. in 2015 from Peking University 🎓, enriched by joint training at Columbia University 🇺🇸 and a visiting scholarship at NYU School of Medicine in 2017 🏥. Her research journey is rooted in the developmental biology of craniofacial organs, exploring mechanisms of aging and regeneration 🦷⏳. She is a pioneer in unveiling how nanomedicine can modulate the bone microenvironment 🔍💊. Through interdisciplinary approaches combining stem cell science, exosomes, and tissue engineering, Dr. Jiang continues to contribute groundbreaking insights to regenerative medicine and biomedical innovation.

Professional Memberships

Dr. Nan Jiang is an active member of the International Association for Dental Research (IADR) 🌍🦷, a globally respected organization that fosters excellence in oral health research. Through her membership, she collaborates with a diverse network of scientists and clinicians, advancing the frontiers of dental and craniofacial research 🔬🤝. Her involvement in IADR provides her with valuable opportunities to share her innovative work on nanomedicine, exosomes, and tissue regeneration at international forums 🌐📢. This professional affiliation strengthens her mission to translate scientific discoveries into real-world therapeutic solutions for oral health and beyond 🧪💡.

Research Focus

Dr. Nan Jiang’s research focus lies at the intersection of regenerative medicine, craniofacial biology, and nanotechnology 🧬🧫. She is particularly recognized for her work in regenerative endodontics, leveraging exosomes, stem cells, and nanomedicine to repair and regenerate dental tissues such as the pulp-dentin complex 🦷💉. Her studies also explore osteogenesis, oral tissue aging, and bone microenvironment modulation, with a special interest in single-cell RNA sequencing for understanding tooth development at a molecular level 🧠🔍. Her multidisciplinary approach is redefining future clinical practices in oral and maxillofacial regenerative therapies 🚀🏥.

Publication Top Notes

Regenerative endodontic therapy: From laboratory bench to clinical practice

Correction: Exosomes derived from human exfoliated deciduous teeth ameliorate adult bone loss in mice through promoting osteogenesis (Journal of Molecular Histology, (2020), 51, 4, (455-466), 10.1007/s10735-020-09896-3)

Advances in tooth development studies based on single-cell RNA sequencing

Abdellatif Benraiss | Gene Therapy |

Published on 16/06/202516/06/2025 by Top Pharmaceutical

Abdellatif Benraiss | Gene Therapy | Best Researcher Award

Dr. Abdellatif Benraiss, Universiy of Rochester, United States

Dr. Abdellatif Benraiss is a distinguished neuroscientist 🧠 specializing in neurobiology, stem cell research 🌱, and gene therapy 🧬. With academic roots in Morocco 🇲🇦 and France 🇫🇷, he earned his Ph.D. in Neurobiology in 1996. His postdoctoral and faculty work in top institutions like Cornell University 🇺🇸 and the University of Rochester has led to pioneering research in Huntington’s disease 🧩, gene transfer therapies 💉, and adult brain regeneration 🧪. He is an esteemed member of several scientific societies 🌍 and a recipient of prestigious awards, including the 2022 Huntington’s Disease Foundation Research Award 🏆.

Publication Profile

Google Scholar

Education

Dr. Abdellatif Benraiss began his academic journey in Morocco 🇲🇦, earning a B.S. in Animal Biology 🐾 from Cadi Ayyad University in 1990. He continued his studies in France 🇫🇷 at Aix-Marseille II University, receiving a second B.S. in Genetics 🧬 in 1991, an M.S. in Neurobiology 🧠 in 1992, and a Ph.D. in Neurobiology in 1996. Pursuing advanced research, he completed a postdoctoral fellowship in Molecular Neurobiology 🔬 at Cornell University Medical College, New York 🇺🇸 (1997–2002), and earned an HDR degree in Gene Therapy 💉 from René Descartes University, Paris, in 2004.

Awards

Dr. Abdellatif Benraiss has been recognized with numerous prestigious honors for his groundbreaking work in neuroscience and gene therapy 🧠💉. In 2022, he received the Huntington’s Disease Foundation Research Award 🧬. He was awarded the NYSTEM Investigator-Initiated Research Project Award in 2011 🧪. His contributions to neurodegenerative disease research earned him the European Leukodystrophy Association (ELA) Award in both 2004 and 2005 🧠🌍. Earlier, in 2003 and 2004, he received fellowships from the French Muscular Dystrophy Association (AFM) 💪🇫🇷. In 2001, he was honored with the Aging Foundation Award from Cornell Medical School 🏛️📜.

Research Focus

Dr. Abdellatif Benraiss’s research focuses on neuroregeneration, gene therapy, and glial cell biology within the context of neurodegenerative diseases 🧠💉. He has pioneered studies on induced neurogenesis in the adult brain, particularly in Huntington’s disease models 🧬, demonstrating how new neurons and glial cells can slow disease progression. His innovative work in gene transfer technologies using viral vectors has contributed to therapies for disorders like metachromatic leukodystrophy and Alzheimer’s disease 🧪. He also explores glial chimerism, aiming to replace diseased brain cells with healthy ones. His multidisciplinary research bridges stem cell therapy, molecular neuroscience, and regenerative medicine 🧫🧍‍♂️.

Publication Top Notes

In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus

Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain

SOX9 is an astrocyte-specific nuclear marker in the adult brain outside the neurogenic regions

Nitric oxide negatively regulates mammalian adult neurogenesis

Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter

Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation

Promoter‐targeted selection and isolation of neural progenitor cells from the adult human ventricular zone

Adenovirally expressed noggin and brain-derived neurotrophic factor cooperate to induce new medium spiny neurons from resident progenitor cells in the adult striatal …

Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer’s …

High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain

Human glia can both induce and rescue aspects of disease phenotype in Huntington disease

Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain

Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease

Neuronal transgene expression in dominant-negative SNARE mice

PDGF-B is required for development of the glymphatic system

Fluorescent Ca²⁺ indicators directly inhibit the Na,K-ATPase and disrupt cellular functions

Haona Bao | Medicinal Chemistry | Best Researcher Award

Published on 16/06/202516/06/2025 by Top Pharmaceutical

Haona Bao | Medicinal Chemistry | Best Researcher Award

Ms. Haona Bao, The Ohio State Univerisity, United States

Ms. Haona Bao is a dynamic Ph.D. candidate in Food Science and Technology at The Ohio State University 🎓. With academic roots at UC Davis and Tennessee State University, her research spans vibrational spectroscopy, food quality, and fibromyalgia diagnostics 🧪. She has published impactful studies on encapsulation, essential oils, and Raman-based detection in top journals 📚. As a teaching assistant, lab safety manager, and award-winning presenter 🏆, she excels in scientific communication and leadership. Haona combines analytical skills, regulatory expertise, and creativity to shape the future of food safety and health innovation 🌾🔬.

Publication Profile

Google Scholar

Education

Ms. Haona Bao is an accomplished scholar with a strong academic foundation in food science. She is currently pursuing her Ph.D. in Food Science and Technology at The Ohio State University (expected August 2025) 🧪. She earned her Master of Science in Food and Animal Science from Tennessee State University between 2019 and 2021 🐓🥼. Her academic journey began at the University of California, Davis, where she obtained her Bachelor of Science in Food Science and Technology in 2019 🍇🔬. Her diverse educational background reflects a deep commitment to advancing innovation in food systems and safety 🌱📘.

Experience

Ms. Haona Bao has extensive research experience in food science and technology. At The Ohio State University (2022–present), she serves as a Doctoral Research Assistant, applying vibrational spectroscopy and multivariate analysis for food quality, adulteration detection, and beer evaluation 🍺📊. She also explores metabolomics for fibromyalgia diagnosis 🧠🧬. As a Teaching Assistant, she supports lab-based courses and student learning 👩‍🏫📝. In her role as Lab Safety Manager, she ensures chemical safety and compliance 🧯⚗️. At Tennessee State University (2019–2021), she developed polymer-based encapsulation, led poultry trials, and contributed to novel packaging innovations.

Awards

Ms. Haona Bao has obtained key certifications that strengthen her expertise in food safety and regulatory compliance. In July 2020, she completed Advanced HACCP and Preventive Controls Training from the Food Safety Net Services (FSNS) 🧼🧪, equipping her with in-depth knowledge of hazard analysis and critical control points. Earlier, in October 2019, she earned certification in Preventive Controls for Human Food from the Food Safety Preventive Control Alliance (FSPCA) 🥫🔍. These credentials highlight her commitment to ensuring safe food production processes and maintaining high industry standards in quality assurance and public health 🏅🌍.

Research Focus

Ms. Haona Bao specializes in Food Science and Analytical Chemistry, with a strong research focus on vibrational spectroscopy, metabolomics, and encapsulation technologies 🧪🌿. Her work bridges food quality control, functional ingredient delivery, and health diagnostics. She applies advanced spectroscopic tools like FT-IR, FT-MIR, and SERS for rapid, non-invasive diagnosis of conditions like fibromyalgia and long COVID 🧠⚡. Additionally, she explores natural polymers and essential oils in encapsulation for food and health applications 🌰🧴. Her cross-disciplinary efforts connect food safety, health monitoring, and chemical fingerprinting, making impactful contributions to nutraceuticals, rheumatology, and food authentication 📊🍷.

Publication Top Notes

Application of yellow mustard mucilage in encapsulation of essential oils and polyphenols using spray drying

Rapid biomarker-based diagnosis of fibromyalgia syndrome and related rheumatologic disorders by portable FT-IR spectroscopic techniques

Metabolic fingerprinting for the diagnosis of clinically similar long COVID and Fibromyalgia using a portable FT-MIR spectroscopic combined with chemometrics

Early diagnosis of fibromyalgia using surface-enhanced raman spectroscopy combined with chemometrics

Portable mid-infrared spectroscopy combined with chemometrics to diagnose fibromyalgia and other rheumatologic syndromes using rapid volumetric absorptive microsampling

Authentication and Quality Control of Distilled Spirits by Vibrational Spectroscopy

Abdulilah Mayet | Neuropharmacology | Excellence in Research

Published on 12/06/202512/06/2025 by Top Pharmaceutical

Abdulilah Mayet | Neuropharmacology | Excellence in Research

Assoc. Prof. Dr. Abdulilah Mayet, King Khalid University, Saudi Arabia

Assoc. Prof. Dr. Abdulilah Mohammad Mayet is an accomplished expert in Electrical Engineering, currently serving at King Khalid University 🇸🇦. With a Ph.D. from KAUST 🎓, he has pioneered research in MEMS/NEMS, nanofabrication, and AI-integrated sensor systems 🤖. A prolific inventor with 8️⃣ patents and 28+ publications 📚, Dr. Mayet has collaborated with global institutions including UC Irvine 🇺🇸 and Cornell University. His leadership spans academia, industry, and innovation 🚀, notably as CEO of Qimam Abha Company and a Fulbright Scholar. Fluent in Arabic and English 🗣️, he inspires innovation across engineering and technology frontiers 🌍.

Publication Profile

Orcid

Education

Assoc. Prof. Dr. Abdulilah Mayet holds a distinguished academic background in Electrical and Electronics Engineering ⚡. He earned his Ph.D. in Electrical Engineering from King Abdullah University of Science and Technology (KAUST) in April 2016 📅, following his M.Sc. in Electrical Engineering from the same institution in June 2011 🧠. His academic journey began with a B.Sc. in Electrical and Electronics Engineering from King Fahd University of Petroleum and Minerals (KFUPM), Dhahran, Saudi Arabia in June 1991 🏫. This strong educational foundation has powered his cutting-edge contributions to nanotechnology, MEMS/NEMS, and semiconductor innovation 🔬🚀.

Experience

Assoc. Prof. Dr. Abdulilah Mayet brings over 25 years of pioneering experience in nanotechnology, MEMS/NEMS, and VLSI design 💡. Currently, he serves as a Supervisor of the VLSI Design Group and a Visiting Professor at UC Irvine, while also being a Fulbright Scholar Fellow 🇺🇸. As an Associate Professor at King Khalid University, he leads initiatives in nanofabrication, AI-driven FPGA teaching, and research commercialization 🧪. Formerly CTO at SEMC, he managed a 4,000m² fab facility. His career spans innovations in NEM switches, amorphous metals, and MEMS platforms, with leadership roles at the Misk 2030 Leaders Program and Saudi Leadership Society 🌍🔬.

Awards

Assoc. Prof. Dr. Abdulilah Mayet has made remarkable contributions to science and engineering, notably by independently conceptualizing and demonstrating the first-ever fully amorphous metal fabricated in a CMOS fab 🧪🔬. He has published 28 journal papers (24 as first/corresponding author) and 7 conference papers 📝. His research has attracted over SAR 26 million in grants, supporting startups and lab establishments 💰. With 8 intellectual properties registered, he continues pushing innovation 🚀. Dr. Mayet has taught a wide range of advanced courses and mentored MSc students 🎓, while actively shaping curriculum development at both undergraduate and graduate levels 📖👨‍🏫.

Research Focus

Assoc. Prof. Dr. Abdulilah Mayet focuses on cutting-edge research in intelligent measurement systems, non-destructive testing (NDT), and sensor-based technologies within the realm of electrical and electronic engineering ⚡. His work integrates artificial intelligence 🤖, machine learning, and ANNs for enhanced precision in multiphase flow analysis, pipeline diagnostics, and material characterization. He also explores nanoelectronics, MEMS/NEMS, and gamma-ray-based detection systems for industrial and biomedical applications 🧠🏭. His multidisciplinary approach bridges engineering with sustainability, fluid mechanics, and healthcare innovation, making his contributions vital to the energy, oil & gas, and emerging technologies sectors 🌍💡.

Publication Top Notes

Multiphase Flow’s Volume Fractions Intelligent Measurement by a Compound Method Employing Cesium-137, Photon Attenuation Sensor, and Capacitance-Based Sensor

Combination of a Nondestructive Testing Method with Artificial Neural Network for Determining Thickness of Aluminum Sheets Regardless of Alloy’s Type

Application of the Fourier Transform to Improve the Accuracy of Gamma-Based Volume Percentage Detection System Independent of Scale Thickness

An Insight to the Outage Performance of Multi-Hop Mixed RF/FSO/UWOC System

Intelligent Measuring of the Volume Fraction Considering Temperature Changes and Independent Pressure Variations for a Two-Phase Homogeneous Fluid Using an 8-Electrode Sensor and an ANN

Proposing a Method Based on Artificial Neural Network for Predicting Alignment between the Saudi Nursing Workforce and the Gig Framework

The Role of Biocomposites and Nanocomposites in Eliminating Organic Contaminants from Effluents

An Intelligent Approach to Determine Component Volume Percentages in a Symmetrical Homogeneous Three-Phase Fluid in Scaled Pipe Conditions

Using Ant Colony Optimization as a Method for Selecting Features to Improve the Accuracy of Measuring the Thickness of Scale in an Intelligent Control System

Experimental Analysis to Detect Corona COVID-19 Virus Symptoms in Male Patients through Breath Pattern Using Machine Learning Algorithms

Application of Artificial Intelligence for Determining the Volume Percentages of a Stratified Regime’s Three-Phase Flow, Independent of the Oil Pipeline’s Scale Thickness

Zhumin Cao | Clinical Trials | Best Researcher Award

Published on 12/06/202512/06/2025 by Top Pharmaceutical

Zhumin Cao | Clinical Trials | Best Researcher Award

Prof. Zhumin Cao, The Seventh People’s Hospital of Chongqing, China

Prof. Zhumin Cao is a dedicated clinician and researcher in vascular diseases 🫀, with extensive experience in both basic and clinical research. He has served as a Visiting Scholar at Ajoy University Hospital 🇰🇷 and Carl Gustav Carus University Hospital 🇩🇪. Prof. Cao has led five funded research projects and published 20+ papers, including 10+ SCI articles with a cumulative impact factor of 40+ 📊. His current focus is on early intracavitary treatment of pulmonary embolism, pioneering innovations in patient care. He is also a reviewer for Angiology and Frontiers 📝.

Publication Profile

Scopus

Education

Prof. Zhumin Cao has dedicated his career to clinical and basic research in vascular diseases 🫀. He has served as a Visiting Scholar at Ajoy University Hospital in South Korea 🇰🇷 and University Hospital Carl Gustav Carus in Germany 🇩🇪. His leadership includes two provincial and three departmental-level projects 📊. He actively contributes to the scientific community as a peer reviewer for Angiology and Frontiers 📝. Prof. Cao has authored over 20 research papers, including 10+ SCI-indexed publications, with a combined impact factor of 40+, and a single article IF reaching 11.4 🌟.

Areas of Research

Prof. Zhumin Cao specializes in the field of vascular diseases 🫀, with a primary research focus on the early treatment of pulmonary embolism 🫁—a life-threatening and time-sensitive condition that poses significant challenges in clinical practice ⏱️. His work aims to improve therapeutic strategies and patient outcomes through intracavitary interventions and innovative approaches in vascular care 💉. By bridging clinical application and basic research, Prof. Cao’s studies contribute meaningfully to the development of evidence-based practices in cardiovascular medicine 🌍. His dedication supports advancements in critical care and interventional procedures that save lives every day ❤️.

Research Focus

Prof. Zhumin Cao’s research delves into the role of Interleukin-6 (IL-6) in reshaping the tumor microenvironment 🧫, a key factor in cancer progression and resistance to therapy. His work explores how IL-6-driven changes affect immune cell behavior and tumor dynamics 🧬. By understanding this cytokine’s influence, he aims to enhance the effectiveness of cancer immunotherapy 💉, offering new avenues for targeted treatments. This research bridges oncology and immunology, contributing to breakthroughs in precision medicine 🧠. Prof. Cao’s findings could lead to improved outcomes for patients battling aggressive cancers through innovative immunomodulatory strategies 🎯.

Publication Top Notes

Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy

Natalia Marina CARDILLO | Drug Discovery and Development | Best Researcher Award

Published on 11/06/202511/06/2025 by Top Pharmaceutical

Natalia Marina CARDILLO | Drug Discovery and Development | Best Researcher Award

Dr. Natalia Marina CARDILLO, USDA-ARS-WSU, United States

Dr. Natalia Marina Cardillo is a distinguished veterinary scientist from Argentina with a Ph.D. in Veterinary Sciences, specializing in parasitology and public health 🧫. Currently a Postdoctoral Research Associate at Washington State University 🇺🇸, she focuses on chemotherapeutic strategies for bovine babesiosis. With over two decades of academic and research excellence across UBA, CONICET, INTA, and USDA, she has led groundbreaking projects on zoonoses, antiparasitic drug resistance, and diagnostics. 🧬 Her contributions span teaching, diagnostics, and pharmaceutical clinical trials in veterinary medicine, earning her global recognition and prestigious fellowships.

Publication Profile

Google Scholar

Education

Dr. Natalia Marina Cardillo began her academic path with a Doctor of Veterinary Medicine degree (1997–2004) from the Universidad de Buenos Aires, Argentina, specializing in Public Health 🐕‍🦺🩺. She furthered her expertise by completing a Ph.D. in Veterinary Sciences with a focus on Parasitology and Public Health (2006–2012), earning the prestigious “summa cum laude” distinction for her thesis on Toxocara cati in murine models 🧬🧫. To complement her academic and research proficiency, she pursued a University Teaching Major in Veterinary and Biological Sciences (2014–2016), strengthening her role as an educator and mentor 📚👩‍🏫.

Experience

Dr. Natalia Marina Cardillo has led a distinguished career in parasitology, veterinary microbiology, and public health. Currently a Postdoctoral Research Associate at Washington State University 🐄💊, she focuses on developing novel treatments for bovine babesiosis. Previously, she served as Senior and Principal Scientist at CONICET-INTA 🇦🇷, leading studies on zoonotic parasitic diseases. With over two decades of academic roles at the Universidad de Buenos Aires 👩‍🏫🧫, she also contributed significantly to diagnostics, laboratory accreditation, and veterinary clinical trials. As founder of ALIANZA InVet 🧬🐕, she has pioneered ethical animal research and advanced pharmaceutical testing across Argentina.

Awards

Dr. Natalia Marina Cardillo has received numerous prestigious honors throughout her career. From 2023 to 2025, she was awarded a competitive Postdoctoral Fellowship by the USDA at Washington State University 🇺🇸🔬. In 2018, she won the NAVES entrepreneurship competition by Universidad Austral’s IAE Business School for her CRO-VET project 🏅💼. Her academic excellence was recognized early with a Ph.D. fellowship (2005–2010) in Public Health Veterinary Medicine and a Scientific Research Scholarship (2000–2002) in Parasitology at Universidad de Buenos Aires 🇦🇷📘—highlighting her dedication to veterinary science and innovation.

Research Focus

Dr. Natalia Marina Cardillo’s research is rooted in veterinary parasitology, with a strong emphasis on zoonotic diseases, public health, and epidemiology 🐛🧫🌍. Her work investigates parasites like Toxocara cati, Trichinella spp., and Aelurostrongylus abstrusus, exploring their life cycles, transmission, and pathology in animal hosts and their public health implications 💉📊. She also focuses on developing chemotherapeutic treatments for diseases such as bovine babesiosis, integrating pharmacology, immunology, and molecular diagnostics 🧬💊. Her interdisciplinary research contributes significantly to One Health, bridging human, animal, and environmental health.

Publication Top Notes

Prevalence of Toxocara cati and other parasites in cats’ faeces collected from the open spaces of public institutions: Buenos Aires, Argentina

Trichinella infection in wild animals from endemic regions of Argentina

Experimental Infection with Toxocara cati in BALB/c Mice, Migratory Behaviour and Pathological Changes

Prevalence of canine dirofilariosis in the city of Buenos Aires and its outskirts (Argentina)

Evaluation of the risk of transmission of Trichinella in pork production systems in Argentina

First report of Toxocara cati in the domestic land snail Rumina decollata

Soil contamination with eggs of Toxocara species in public parks of Karaj, Iran

Clinical, haematological, biochemical and economic impacts of Trichinella spiralis infection in pigs

First report of Aelurostrongylus abstrusus in domestic land snail Rumina decollata, in the Autonomous city of Buenos Aires

EXPERIMENTAL INFECTION WITH Toxocara cati IN PIGS: MIGRATORY PATTERN AND PATHOLOGICAL RESPONSE IN EARLY PHASE

Nuevos aportes al conocimiento de Trichinella y trichinellosis

IOANNIS VAMVAKARIS | Precision Medicine | Best Researcher Award

Published on 11/06/202511/06/2025 by Top Pharmaceutical

IOANNIS VAMVAKARIS | Precision Medicine | Best Researcher Award

Dr. IOANNIS VAMVAKARIS, IATROPOLIS, Greece

Dr. Ioannis Vamvakaris is a distinguished Greek pathologist specializing in thoracic pathology. 🫁 He earned his MSc in Thoracic Oncology in 2013 and PhD in 2018 from Athens School of Medicine. 🎓 Since 2019, he has led the Pathology Department at Sotiria General Hospital. 🏥 He’s authored over 200 publications 📚 and co-developed Greece’s first AI software for pathology. 🤖 A reviewer for top journals (Elsevier, MDPI), he actively collaborates on global research in cancer, organoids, proteomics, and microbiome. 🌍 Recognized with the 2024 Best Researcher Award 🏆 and Sigma Xi membership, Dr. Vamvakaris continues to shape medical science with dedication and innovation.

Publication Profile

Google Scholar

Education

Dr. Ioannis Vamvakaris is a highly accomplished pathologist who began his medical journey at Sotiria General Hospital in Athens 🏥. Since 2008, he has served as a consultant in the pathology department, demonstrating unwavering dedication to thoracic pathology 🫁. He earned his MSc in Thoracic Oncology in 2013 and completed his PhD in 2018 from the Athens School of Medicine 🎓. Dr. Vamvakaris also pursued specialized training in Patient-Crisis-Emergency Management at the Berlin School of Economics 🇩🇪. His academic growth and professional excellence highlight his strong commitment to advancing medical knowledge and enhancing patient care globally 🌍.

Awards

Dr. Ioannis Vamvakaris has earned prestigious honors in recognition of his exceptional contributions to pathology and oncology research 🔬. In 2024, he was presented with the Best Researcher Award at the International Research Awards on Oncology and Cancer Research 🧬. That same year, he was inducted as an Associate Member of Sigma Xi 🧠—a globally respected scientific research honor society that recognizes excellence through nomination only. Additionally, he received the Trusted Reviewer Certificate in 2023 📄, reflecting his outstanding commitment to scientific publishing and peer evaluation. These accolades underscore his leadership and integrity in medical science 🌟.o

Research Focus

Dr. Ioannis Vamvakaris is a leading expert in thoracic pathology, with a strong research focus on lung cancer, molecular oncology, and immunopathology 🔬. His studies span non-small cell lung cancer (NSCLC), checkpoint inhibitor-induced sarcoidosis, and PD-1/PD-L1 immune responses 🧬. His collaborative work explores liquid biopsy biomarkers, xenograft models, and AI-assisted diagnostics 🤖. Passionate about translational research, he contributes to genomics, proteomics, fibrosis, and epigenetics in thoracic malignancies. His multidisciplinary efforts bridge clinical pathology and personalized medicine, advancing early diagnosis and targeted therapies 💉. Dr. Vamvakaris’ research enriches global understanding of lung diseases and thoracic oncology 🌍.

Publication Top Notes

Sarcoidosis-like reactions induced by checkpoint inhibitors

Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts

Epithelial–mesenchymal transition in non small-cell lung cancer

Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer

Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma

DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection

Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy

Salivary inflammatory markers in tension type headache and migraine: the SalHead cohort study

Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic …

An immunohistochemical evaluation of the proteins W nt1 and glycogen synthase kinase (GSK)‐3β in invasive breast carcinomas

Pulmonary blastoma: a comprehensive overview of a rare entity

Preoperative mutational analysis of circulating tumor cells (CTCs) and plasma-cfDNA provides complementary information for early prediction of relapse: A pilot study in early …

Valory Anne Vailoces | Ophthalmic Pharmacology | Best Researcher Award

Published on 10/06/202510/06/2025 by Top Pharmaceutical

Valory Anne Vailoces | Ophthalmic Pharmacology | Best Researcher Award

Ms. Valory Anne Vailoces, George Washington University School of Medicine & Health Sciences, United States

Ms. Valory Anne Vailoces is a dedicated biomedical scientist and medical student at George Washington University School of Medicine and Health Sciences. She earned her B.S. in Biomedical Sciences from the University of Central Florida in 2021 🎓. Valory conducts impactful ophthalmology research 👁️ under Dr. Michael Tolentino and collaborated with the Miami Itch Center on dermatological studies 🧬. Her pioneering work on rifampicin eye drops for age-related macular degeneration led to a preclinical IND application 💊. She also serves as a senior officer at Hearts for the Homeless International ❤️, combining science with social service.

Publication Profile

Orcid

Education

Valory Anne S. Vailoces earned her B.S. in Biomedical Sciences in 2021 from the University of Central Florida 🧬. She is currently pursuing her medical degree at the George Washington University School of Medicine and Health Sciences 🏥. Alongside her studies, she is actively involved in ophthalmology research 👁️ under the mentorship of Dr. Michael Tolentino. Valory also serves as a senior officer for Hearts for the Homeless International ❤️, a non-profit organization that delivers preventative healthcare services 🩺 to underserved and homeless populations, demonstrating her deep commitment to both science and social impact 🌍.

Professional Memberships

Ms. Valory Anne Vailoces does not currently hold memberships in professional organizations 🤝, her dedication to academic excellence and impactful research in ophthalmology, dermatology, and health management 🧠👁️📊 stands out on its own. Her active involvement in translational research, along with her service to the community through Hearts for the Homeless International ❤️, reflects a strong commitment to both science and humanity 🌍. As she continues to advance in her medical education and research career 🧬, professional affiliations are expected to follow as a natural progression of her growing influence in the field 🚀.

Research Focus

Ms. Valory Anne Vailoces focuses her research on ophthalmology, dermatology, and therapeutic innovation 🧪👁️🧴. Her groundbreaking work includes developing rifampicin eye drops for treating exudative age-related macular degeneration (AMD) 🧬, a major cause of vision loss worldwide 🌍. Additionally, she explores immune-modulating therapeutic nanoparticles for safer clinical applications and leads investigations into aquagenic pruritus, a rare skin condition causing severe itching 💧🧖‍♀️. Through a blend of biomedical science, nanomedicine, and patient-centered studies, Valory contributes to advancing precision treatment modalities with the potential to transform clinical practice 🚀🩺. Her work spans innovative drug delivery and patient quality-of-life research.

Publication Top Notes

Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration

Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials

Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives

Jian Shi | Precision Medicine | Best Researcher Award

Published on 10/06/202510/06/2025 by Top Pharmaceutical

Jian Shi | Precision Medicine | Best Researcher Award

Assoc. Prof. Dr. Jian Shi, Neurology of UCSF, United States

Assoc. Prof. Dr. Jian Shi is a distinguished neuroscientist at the University of California, San Francisco, with a Ph.D. in Neurobiology from Navy Medical University, China. 🧬 He completed postdoctoral training at the University of Texas Southwestern Medical Center, focusing on neuroscience. His research integrates brain injury, neurodegenerative diseases, and glioblastoma with cutting-edge AI and bioinformatics tools. 🧪🧠 Dr. Shi has authored highly cited publications and received numerous accolades, including the APS Outstanding Paper Award. 🌟 A dedicated mentor and educator, he actively contributes to diversity and public service in neurology and biomedical research.

Publication Profile

Google Scholar

Education

Assoc. Prof. Dr. Jian Shi began his academic journey at the National University of Defense Technology in Hunan Province, China, earning both his B.S. and M.S. degrees in Biomechanics. ⚙️📘 He then pursued his Ph.D. in Neurobiology under the mentorship of Dr. Lu Changlin at the prestigious Navy Medical University in Shanghai. 🧬🏥 Driven by a passion for neuroscience, he completed his postdoctoral training at the University of Texas Southwestern Medical Center under the guidance of Dr. Steven G. Kernie, focusing on advanced neuroscience research. 🧠🔬 His academic foundation bridges biomechanics and cutting-edge neurobiological science.

Awards

Assoc. Prof. Dr. Jian Shi has received numerous accolades recognizing his excellence in research and education. 🇨🇳 He was honored with the prestigious National Award for Scientific Progress, Level 2 in China 🥇🔬 and received the Award for Outstanding Scientists from Navy Medical University, where he also earned the Best Teacher Award for his commitment to academic excellence 👨‍🏫🌟. His groundbreaking work earned him the “Top 50 Most Cited Article Award” from the Journal of Clinical Medicine 📖📈 and the APS Outstanding Paper Award from Acta Pharmacologica Sinica 🧪🏅. He is also recognized as a Trusted Reviewer by the International Journal of Molecular Sciences 🧠✅.

Research Focus

Assoc. Prof. Dr. Jian Shi’s research centers around neurobiology, with a strong emphasis on traumatic brain injury (TBI) 🧠💥, neurodegeneration 🧬, neurogenesis 🌱, and molecular neuroscience. His work explores small molecule therapies, microglial activation, intranasal drug delivery 💊, and microRNA biomarkers, particularly in the context of glioblastoma and stroke. He also investigates brain repair mechanisms, exosomal signaling 📦, and neurotrophin-mimetic compounds. In recent years, his interdisciplinary work has extended to climate impact models 🌍 and machine learning applications 🤖 in brain science, reflecting a comprehensive and innovative research portfolio in translational neuroscience and brain health.